A Phase 2b, Randomized, Placebo-Controlled, Observer-Blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Respiratory Syncytial Virus (RSV) Vaccine In Pregnant Women 18 Through 49 Years Of Age And Their Infants
- Buttery, Jim (Primary Chief Investigator (PCI))
Project: Research